Get notified when REPL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: REPL Replimune Group, Inc. 10-Q/A

Replimune amends 10-Q to disclose three executives' Rule 10b5-1 trading plans

Filed November 6, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 28, 2026 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-Q (same period end Sep 30, 2026). This amendment updates disclosure only — see the diff below.

Key Changes

  • medium

    The amendment adds previously omitted Rule 10b5-1 trading arrangements for Executive Chair Philip Astley-Sparke, CEO Sushil Patel, and CMO Konstantinos Xynos entered during the quarter ended September 30, 2026.

    Item 5. Other Information verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (OWL 10-Q) is open in full — no account needed.

Partner

Trade REPL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify